| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.2M | -0.4% |
| Cost of Revenue | $2.0M | +284.2% |
| R&D Expense | $6.5M | +125.8% |
| SG&A Expense | $22.9M | +317.3% |
| Operating Income | -$27.2M | -481.0% |
| Income Tax | $1K | +0.0% |
| Net Income | -$72.5M | -1383.7% |
| EPS (Basic) | -$4.37 | -694.5% |
| EPS (Diluted) | -$4.37 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.4M | +1321.9% |
| Accounts Receivable | $1.9M | +88.7% |
| Inventory | $11.1M | +956.4% |
| Current Assets | $46.8M | +881.6% |
| Total Assets | $52.9M | +639.5% |
| Current Liabilities | $9.5M | +18.0% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.2M | -848.1% |
| Capital Expenditures | $273K | +1113.7% |
| Investing Cash Flow | -$265K | -1079.7% |
| Financing Cash Flow | $59.7M | +1039.7% |
| Free Cash Flow | -$29.5M | -850.0% |
| -694.5% |
| Total Liabilities |
| $23.0M |
| +186.2% |
| Stockholders' Equity | $29.5M | +3451.2% |